title: How should we care for atopic dermatitis?
authors.affiliation: University of Cincinnati Family Practice Residency, Wilmington, OH, USA. keholtenmd@cmhregional.com
authors.forename: Keith B
authors.initials: KB
authors.lastname: Holten
mesh_terms: D000284:Administration, Oral; D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D003876:Dermatitis, Atopic / Q000175:diagnosis / Q000188:drug therapy*; D005194:Family Practice / Q000592:standards; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D011379:Prognosis; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D016559:Tacrolimus / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; C117268:pimecrolimus; D016559:Tacrolimus